Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria (Q39579022)

13 September 2017

title

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. (English)

1 reference

13 September 2017

0 references

1 reference

9

1 reference

13 September 2017

G Severi

7

0 references

author name string

G Bartsch

1

1 reference

13 September 2017

W Horninger

2

1 reference

13 September 2017

H Klocker

3

1 reference

13 September 2017

A Reissigl

4

1 reference

13 September 2017

W Oberaigner

5

1 reference

13 September 2017

D Schönitzer

6

1 reference

13 September 2017

C Robertson

8

1 reference

13 September 2017

Tyrol Prostate Cancer Screening Group

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

13 September 2017

1 reference

13 September 2017

volume

58

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

417-424

1 reference

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

The Nature of Prostate Cancer Detected Through Prostate Specific Antigen Based Screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Screening for prostate cancer: an analysis of the early experience

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Frequency and clinical significance of transition zone cancer in prostate cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Prostate carcinoma screening in the county of Tyrol, Austria: experience and results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Epidemiology of prostate cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Screening digital rectal examination and prostate cancer mortality: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Prostate specific antigen (PSA) testing as screening for prostate cancer: The current controversy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Reduction in breast cancer mortality due to the introduction of mass screening in The Netherlands: comparison with the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic Tests

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901264-X

7 January 2021

10.1016/S0090-4295(01)01264-X

Identifiers

DOI

1 reference

13 September 2017

1 reference